Form 8-K - Current report:
SEC Accession No. 0001213900-24-081799
Filing Date
2024-09-25
Accepted
2024-09-25 16:05:31
Documents
48
Period of Report
2024-09-25
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0215596-8k_cadrenal.htm   iXBRL 8-K 29152
2 INVESTOR PRESENTATION OF CADRENAL THERAPEUTICS, INC. DATED SEPTEMBER 2024 ea021559601ex99-1_cadrenal.htm EX-99.1 52428
3 GRAPHIC ex99-1_001.jpg GRAPHIC 223255
4 GRAPHIC ex99-1_002.jpg GRAPHIC 395160
5 GRAPHIC ex99-1_003.jpg GRAPHIC 378370
6 GRAPHIC ex99-1_004.jpg GRAPHIC 246609
7 GRAPHIC ex99-1_005.jpg GRAPHIC 242384
8 GRAPHIC ex99-1_006.jpg GRAPHIC 224756
9 GRAPHIC ex99-1_007.jpg GRAPHIC 236654
10 GRAPHIC ex99-1_008.jpg GRAPHIC 400754
11 GRAPHIC ex99-1_009.jpg GRAPHIC 364522
12 GRAPHIC ex99-1_010.jpg GRAPHIC 220945
13 GRAPHIC ex99-1_011.jpg GRAPHIC 307851
14 GRAPHIC ex99-1_012.jpg GRAPHIC 241469
15 GRAPHIC ex99-1_013.jpg GRAPHIC 183357
16 GRAPHIC ex99-1_014.jpg GRAPHIC 302813
17 GRAPHIC ex99-1_015.jpg GRAPHIC 248777
18 GRAPHIC ex99-1_016.jpg GRAPHIC 219091
19 GRAPHIC ex99-1_017.jpg GRAPHIC 181085
20 GRAPHIC ex99-1_018.jpg GRAPHIC 382418
21 GRAPHIC ex99-1_019.jpg GRAPHIC 239816
22 GRAPHIC ex99-1_020.jpg GRAPHIC 286175
23 GRAPHIC ex99-1_021.jpg GRAPHIC 345069
24 GRAPHIC ex99-1_022.jpg GRAPHIC 188603
25 GRAPHIC ex99-1_023.jpg GRAPHIC 265731
26 GRAPHIC ex99-1_024.jpg GRAPHIC 262970
27 GRAPHIC ex99-1_025.jpg GRAPHIC 157479
28 GRAPHIC ex99-1_026.jpg GRAPHIC 268876
29 GRAPHIC ex99-1_027.jpg GRAPHIC 277839
30 GRAPHIC ex99-1_028.jpg GRAPHIC 318502
31 GRAPHIC ex99-1_029.jpg GRAPHIC 301990
32 GRAPHIC ex99-1_030.jpg GRAPHIC 248381
33 GRAPHIC ex99-1_031.jpg GRAPHIC 163346
34 GRAPHIC ex99-1_032.jpg GRAPHIC 236801
35 GRAPHIC ex99-1_033.jpg GRAPHIC 308172
36 GRAPHIC ex99-1_034.jpg GRAPHIC 216770
  Complete submission text file 0001213900-24-081799.txt   12132089

Data Files

Seq Description Document Type Size
37 XBRL SCHEMA FILE cvkd-20240925.xsd EX-101.SCH 3015
38 XBRL LABEL FILE cvkd-20240925_lab.xml EX-101.LAB 34240
39 XBRL PRESENTATION FILE cvkd-20240925_pre.xml EX-101.PRE 22359
50 EXTRACTED XBRL INSTANCE DOCUMENT ea0215596-8k_cadrenal_htm.xml XML 3799
Mailing Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Filer) CIK: 0001937993 (see all company filings)

EIN.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41596 | Film No.: 241324110
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)